Executive Summary Vasomotor Menopausal Symptoms (VMS) Treatment Market Research: Share and Size Intelligence
The global vasomotor menopausal symptoms (VMS) treatment market size was valued at USD 18.85 billion in 2024 and is expected to reach USD 30.50 billion by 2032, at a CAGR of 6.20% during the forecast period.
Best-practice models...